Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
28,089,346
-
Total 13F shares
-
109,483,058
-
Share change
-
-615,998
-
Total reported value
-
$336,089,717
-
Put/Call ratio
-
219%
-
Price per share
-
$3.07
-
Number of holders
-
104
-
Value change
-
-$11,584,564
-
Number of buys
-
55
-
Number of sells
-
50
Institutional Holders of GeneDx Holdings Corp. - Class A Common Stock (WGS) as of Q1 2022
As of 31 Mar 2022 GeneDx Holdings Corp. - Class A Common Stock (WGS) had 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 109,483,058 shares of stock of the company.
Largest 10 holders included Blackstone Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), SB Management Ltd, VANGUARD GROUP INC, Casdin Capital, LLC, MARSHALL WACE, LLP, Corvex Management LP, Third Point LLC, ORACLE INVESTMENT MANAGEMENT INC, and Decheng Capital Management III (Cayman), LLC.
This table shows 104 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.